Published in Arch Intern Med on March 10, 2003
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study. JAMA Intern Med (2014) 2.05
Racial disparity in hypertension control: tallying the death toll. Ann Fam Med (2008) 1.54
Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review. Ann Fam Med (2007) 1.54
Treatment of hypertension among African Americans: the Jackson Heart Study. J Clin Hypertens (Greenwich) (2013) 1.52
Behavioral strategies for cardiovascular risk reduction in diverse and underserved racial/ethnic groups. Circulation (2012) 1.19
A multilevel assessment of barriers to adoption of Dietary Approaches to Stop Hypertension (DASH) among African Americans of low socioeconomic status. J Health Care Poor Underserved (2011) 1.16
Interactions between metallopeptidase 3 polymorphism rs679620 and BMI in predicting blood pressure in African-American women with hypertension. J Hypertens (2008) 1.16
Relation between socioeconomic status, race-ethnicity, and left ventricular mass: the Northern Manhattan study. Hypertension (2004) 1.15
Physician-patient racial concordance, continuity of care, and patterns of care for hypertension. Am J Public Health (2005) 1.14
Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients. Am J Kidney Dis (2011) 1.09
Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgrad Med (2009) 1.07
Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc (2004) 1.06
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med (2004) 1.05
A barber-based intervention for hypertension in African American men: design of a group randomized trial. Am Heart J (2009) 1.05
The role of anemia management in improving outcomes for African-Americans with chronic kidney disease. Am J Nephrol (2008) 1.04
Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics (2008) 1.04
Impact of poverty on hypertension and cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr (2007) 1.04
Genetic and environmental risks for high blood pressure among African American mothers and daughters. Biol Res Nurs (2009) 1.04
Genetic and BMI risks for predicting blood pressure in three generations of West African Dogon women. Biol Res Nurs (2011) 0.97
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension. J Hum Hypertens (2010) 0.94
Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci (2014) 0.94
Disease management to promote blood pressure control among African Americans. Popul Health Manag (2010) 0.94
Biology of ageing and role of dietary antioxidants. Biomed Res Int (2014) 0.93
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Measuring blood pressure knowledge and self-care behaviors of African Americans. Res Nurs Health (2008) 0.91
Improving blood pressure control: results of home-based post-acute care interventions. J Gen Intern Med (2010) 0.91
A cluster-randomized controlled trial evaluating the effect of culturally-appropriate hypertension education among Afro-Surinamese and Ghanaian patients in Dutch general practice: study protocol. BMC Health Serv Res (2009) 0.90
Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc (2011) 0.89
Hypertension in women: part I. J Clin Hypertens (Greenwich) (2008) 0.88
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. J Natl Med Assoc (2006) 0.87
Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria. BMC Cardiovasc Disord (2009) 0.86
Influence of patient race on physician prescribing decisions: a randomized on-line experiment. J Gen Intern Med (2009) 0.85
Understanding the complexity of hypertensive African American home care patients: challenges to intervention. Ethn Dis (2009) 0.84
Cardiovascular disease and African Americans: why determination of race is inadequate for research and practice. J Natl Med Assoc (2007) 0.84
Qualitative analysis of peer coaches' experiences with counseling African Americans about reducing heart disease risk. J Gen Intern Med (2011) 0.84
Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide. Int J Clin Pract (2007) 0.83
New recommendations for treating hypertension in black patients: evidence and/or consensus? Hypertension (2010) 0.83
Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes. Schizophr Res (2008) 0.83
Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women. J Natl Black Nurses Assoc (2009) 0.83
Executive summary of the African-American Initiative. MedGenMed (2007) 0.82
Traditional games resulted in post-exercise hypotension and a lower cardiovascular response to the cold pressor test in healthy children. Front Physiol (2014) 0.81
Why is control of hypertension in sub-Saharan Africa poor? Cardiovasc J Afr (2015) 0.80
Relationship of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension. Workplace Health Saf (2012) 0.80
The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc (2005) 0.80
Applying qualitative methods in developing a culturally tailored workbook for black patients with hypertension. Patient Educ Couns (2009) 0.80
Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients. Trials (2012) 0.80
Depressive symptoms and cognitive decline in older african americans: two scales and their factors. Am J Geriatr Psychiatry (2014) 0.80
Cardiac troponin I Pro82Ser variant induces diastolic dysfunction, blunts β-adrenergic response, and impairs myofilament cooperativity. J Appl Physiol (1985) (2014) 0.79
The role of stress and social support in predicting depression among a hypertensive African American sample. Heart Lung (2008) 0.79
Weight status and high blood pressure among low-income African American men. Am J Mens Health (2010) 0.79
Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification. BMJ (2008) 0.78
A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife women. Maturitas (2011) 0.78
The contributions of muscarinic receptors and changes in plasma aldosterone levels to the anti-hypertensive effect of Tulbaghia violacea. BMC Complement Altern Med (2013) 0.78
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. J Am Soc Hypertens (2011) 0.78
The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic. J Am Soc Hypertens (2015) 0.78
Diuretic use in black patients with uncontrolled hypertension. Am J Hypertens (2012) 0.77
Medical and psychological risk factors for incident hypertension in type 1 diabetic african-americans. Int J Hypertens (2011) 0.77
Hypertension and hypertensive heart disease in African women. Clin Res Cardiol (2014) 0.76
Short-term trends in heart failure-related hospitalizations in a high-risk state. South Med J (2013) 0.76
Pilot study evaluating the effects of an intervention to enhance culturally appropriate hypertension education among healthcare providers in a primary care setting. Implement Sci (2010) 0.76
Chronotherapeutic oral drug absorption system verapamil is effective in reducing morning blood pressure in African Americans: a post hoc analysis of the chrono trial. J Natl Med Assoc (2005) 0.76
Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76
Depressive symptomatology and respiratory sinus arrhythmia in a non-clinical sample of middle-aged African Americans. Biol Psychol (2015) 0.76
Questioning race-based hypertension management. Arch Intern Med (2003) 0.75
The effects of urate lowering therapy on inflammation, endothelial function, and blood pressure (SURPHER) study design and rationale. Contemp Clin Trials (2016) 0.75
Risk factors for acute non-ST-segment elevation myocardial infarction in a population sample of predominantly African American patients with chest pain and normal coronary arteries. Ethn Dis (2011) 0.75
Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility. Integr Blood Press Control (2009) 0.75
The approach of general practitioners in Lagos to the detection and evaluation of hypertension. Clin Hypertens (2015) 0.75
Aliskiren and valsartan combination therapy for the management of hypertension. Vasc Health Risk Manag (2010) 0.75
Hypertension in women--part II. J Clin Hypertens (Greenwich) (2008) 0.75
High blood pressure in African Americans. Arch Intern Med (2003) 0.75
Postmarketing surveillance study of benazepril in chinese patients with hypertension: An open-label, experimental, epidemiologic study. Curr Ther Res Clin Exp (2004) 0.75
TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats. Int J Hypertens (2011) 0.75
Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study). Curr Ther Res Clin Exp (2004) 0.75
Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy. Drugs R D (2012) 0.75
Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects. PLoS One (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med (2013) 8.74
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med (2014) 5.93
Metformin: an update. Ann Intern Med (2002) 5.62
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med (2005) 5.09
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol (2012) 4.56
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation (2011) 3.95
Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension (2006) 3.89
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Role of mitochondrial dysfunction in insulin resistance. Circ Res (2008) 3.45
Endothelial dysfunction. J Am Soc Nephrol (2004) 3.18
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) (2013) 2.94
Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2003) 2.86
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens (2014) 2.82
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension (2011) 2.82
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol (2008) 2.63
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate. Arch Intern Med (2006) 2.56
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol (2003) 2.47
Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol (2010) 2.43
The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab (2008) 2.34
Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 2.29
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 2.28
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res (2002) 2.27
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med (2009) 2.25
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2005) 2.13
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension (2006) 2.12
Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med (2008) 2.11
Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail (2009) 2.09
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation (2002) 2.07
T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension (2011) 2.03
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol (2005) 2.03
Inflammation in hypertension. Curr Opin Nephrol Hypertens (2006) 2.01
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol (2007) 2.01
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension (2015) 2.01
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation (2011) 1.97
Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci (2008) 1.97
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J (2012) 1.95
Hypertension, angiotensin II, and oxidative stress. N Engl J Med (2002) 1.92
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) (2010) 1.90
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg (2003) 1.83
Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation (2008) 1.82
Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension (2002) 1.81
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension (2006) 1.80
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) (2007) 1.79
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med (2005) 1.76
Barbershops as hypertension detection, referral, and follow-up centers for black men. Hypertension (2007) 1.74
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med (2002) 1.73
Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol (2004) 1.73
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors. J Natl Cancer Inst (2010) 1.73
CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.71
Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 1.71
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol (2007) 1.71
Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension (2011) 1.69
Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice. Arterioscler Thromb Vasc Biol (2011) 1.69
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67
Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension (2004) 1.67
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Can J Cardiol (2006) 1.67
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. Am J Hypertens (2004) 1.67